Clinopodium chinense Attenuates Palmitic Acid-Induced Vascular Endothelial Inflammation and Insulin Resistance through TLR4-Mediated NF-


Journal

The American journal of Chinese medicine
ISSN: 1793-6853
Titre abrégé: Am J Chin Med
Pays: Singapore
ID NLM: 7901431

Informations de publication

Date de publication:
2019
Historique:
entrez: 20 2 2019
pubmed: 20 2 2019
medline: 16 3 2019
Statut: ppublish

Résumé

Elevated palmitic acid (PA) levels are associated with the development of inflammation, insulin resistance (IR) and endothelial dysfunction. Clinopodium chinense (Benth.) O. Kuntze has been shown to lower blood glucose and attenuate high glucose-induced vascular endothelial cells injury. In the present study we investigated the effects of ethyl acetate extract of C. chinense (CCE) on PA-induced inflammation and IR in the vascular endothelium and its molecular mechanism. We found that CCE significantly inhibited PA-induced toll-like receptor 4 (TLR4) expression in human umbilical vein endothelial cells (HUVECs). Consequently, this led to the inhibition of the following downstream adapted proteins myeloid differentiation primary response gene 88, Toll/interleukin-1 receptor domain-containing adaptor-inducing interferon-

Identifiants

pubmed: 30776912
doi: 10.1142/S0192415X19500058
doi:

Substances chimiques

Blood Glucose 0
NF-kappa B 0
Plant Extracts 0
Toll-Like Receptor 4 0
Palmitic Acid 2V16EO95H1
Nitric Oxide 31C4KY9ESH
Nitric Oxide Synthase Type III EC 1.14.13.39
Mitogen-Activated Protein Kinases EC 2.7.11.24
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-117

Auteurs

Xiaoji Shi (X)

* Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Shanshan Wang (S)

* Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Huiling Luan (H)

* Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Dina Tuerhong (D)

* Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Yining Lin (Y)

† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Jingyu Liang (J)

‡ Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.

Yi Xiong (Y)

§ Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, USA.

Liangyou Rui (L)

§ Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, USA.

Feihua Wu (F)

* Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
† Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
§ Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH